Clinical Scorecard: Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

At a Glance

Key Highlights

• Invasive strategy did not reduce cardiovascular death or nonfatal myocardial infarction compared to conservative management.
• Higher frailty levels were associated with worse outcomes in invasive management.
• 38% of invasive care patients experienced primary outcome versus 29% in conservative care.
• Procedural complications were numerically more common in frail patients undergoing invasive treatment.
• Findings suggest frailty modifies the balance of benefit and risk with invasive strategies.

Guideline-Based Recommendations

Diagnosis

• Assess frailty using Fried frailty criteria in patients with NSTEMI.

Management

• Consider conservative management for frail patients with NSTEMI.

Monitoring & Follow-up

• Monitor for procedural complications in frail patients undergoing invasive procedures.

Risks

• Be aware of potential harm associated with invasive strategies in patients with higher frailty.

Patient & Prescribing Data

Frail patients aged 75 years or older with NSTEMI.

Invasive management may not provide expected benefits and could increase risks in frail patients.

Clinical Best Practices

• Evaluate frailty severity when making treatment decisions for older patients.
• Utilize conservative management strategies in frail patients with NSTEMI.

References

• SENIOR-RITA Trial